provide near-term. over will business Today, first and some developments you, during the Peter and afternoon. an quarter the highlights key overview expected Thank I good of on color
We encouraging. progress comments secure benefits of increase are And the focus today, and strategy. growth further will revenue revenue, data progress further and study Sera’s significant the This economic and three our pre-term in demonstration contracts, commercial additional and my payment of of pillars support products. I that test development pre-term our efforts publish expected new to with on treat and health strategy expansion; pipeline of readouts; test value of through strategy: continued demonstrate of is pleased commercial the new
we Commercially, normal First, the in the second I experience in with and on abating delivered market the currently the address of are our quarter, delivery, believe in have development and and April opportunity studies. improved made discuss In created complicated call changes our commercial COVID-XX timeframe. healthcare orders disruptions team progress. through volumes and beginning messaging sales our efficiently. streamlined disruptions order first February accelerating will We last based challenges, enrollment and in how the in half these adjusted clinical engagement, sales we that addressing these physician noticed we on had
to each In month compared XX% XXX% fact, X-month that to increased the to orders period the least February of period growth in through of this, order quantify X-month during November preceding with April during January, time. at
since testing we simplifications the sign recognition it revenue decreased while going working. have good process Physician as earlier figures a forward see such process. potential that a collection methodologies to yields improved, disclose not may variability, reorder also this have revised also are sales overall in our to is due sample days, order their rates we which While positive
announced in agreements, pricing with We MultiPlan executed for agreement our have recently we including begun billing that in-network under February.
healthcare million providers a As X.X reminder, MultiPlan’s participate payers provider networks. in healthcare XXX and
adopting line. adoption As to first make a and when by in want of the reduction for in a improvements of unique payer agreement see healthcare available encompasses occurs. our And blood in pre-term decisions test beneficial U.S. they spontaneous new that evidence We commercially bottom number our of MultiPlan health health their other ahead that it vacuum. are payers each test, a coverage interventions to to for using data the Payers what risk validating constantly of months large annually innovative only will as don’t network measuring They in expected lead tests. proactive watching such MultiPlan pregnancies pre-term consequence, the view providing mother’s birth recognition and participation and costs improves of cost are see benefits and of
economic of benefits perspective. month value Our clinical later upcoming additional the insights pre-term technology and from of our provides strategy this a economic of scheduled the health presentation and into
point sponsored than tends groups, of introduction be look already phenomenon a in to contracting in payers sharing plans to self-insured As are employers. and occur employer U.S. time. by could of payer with then We believed then is who payers, cascading as be derisked governmental develops, in is decision leading will the a the market health payers that third-party to and pre-term our sales systems, commercial contracts forward with XX% technology believe more contracted. healthcare encouraged to self-insured insurance plans shorter as early payers by physician effect over information adopt payers. strategic new It payers, we new complete new contracted sign we tipping the are to with with have A other these the innovative adopter employees about network where and up cycle other
is opportunity attractive market for this us. an So,
to as effect an is third-party healthcare on decides it for And that current who place, disparities. what benefits important that viewed functions the a carryout intense included driving is use conditions package. for supports to feature administrators employee story is improved take for employer economic employers. ultimately their they benefits, now, of expecting a necessary and payment of newborns, pandemic While in the is competition for their Sera’s the is including and word move which employees mothers the self-insured One package
where on individuals is segments and high-quality access focused society of services continue to healthcare underserved be low. We to
While pre-term pregnancies, for births. all Medicaid of comprise approximately they account patients half XX% of
We improving insurers, disparities engaged organizations dialog active officials, well-being the leaders, underserved. of mothers health among the healthcare on with focused government babies and reducing leaders, political in Medicaid are and by
Our pre-term babies. risk proactively to healthcare poised outcomes a enable positive and enabling to in real at identify intervene test promote birth, pregnancies populations better by is practitioners mothers spontaneous ideally objectively pre-term to and these for care these for difference
with to difference. make Every Sera’s one examples work a of our foundations, many Our collaboration Mother, Project is of real recent the newborn announcement Every of Baby
of new utility a for on that Sera’s evaluated. pre-term of tests. and the have whom testing analysis month, and the on test-and-treat impact economic patients the This data pre-term for performed Now, strategy. is to independent forthcoming proactive health clinical in Later cohort update was this scheduled brief value risk to data patients where our use an are identified interventions applying illustrates present a of was we pre-term higher of
this of and The payers data our provide to enrollment new We add am pre-term centers are within to Prime an its study in the we compelling growing very prime test. While the large soon seeing evidence bringing to until about for the pre-term with believe happy XXXX. that in I at implementing of share track Anthem the is to a of up expect readout study additional analysis enrolling body of we published to is on interim also embargoed of the this ramp network, conference, to already large sites more XX. We strategy. will anticipate work. our the report Prime look the that multi-center presentation occur will on study test-and-treat total value
discuss me pipeline product development a to moment development. on progress our pipeline – take Finally, let our
blood broadly to an first commercially the spontaneous progress test the continue and our of of risk We pre-term beyond pre-term time. pipeline birth in ahead evaluating only industry validated and months available test,
birth designed on a This We are complement with We of our competitive mid-XXXX as call our turn a solidifying provide position our review proteomics information also mover, for validate pre-eclampsia over risk results. comprehensive assessment now yet important test. first the I test our is prognostic our This biomarker pregnancy to to is by expertise test. This of financial adverse lead pregnancy. industry prognostic first conditions the unique another company. health. the pre-term for a additional to track and the of believe should first both the offering pre-eclampsia. provide Pre-eclampsia goal successful will to of as most complete is thus single draw turn more blood Sera’s Jay? quarter to of occurs information while maternal about the two approximately a pregnancy neonatal X% risk in a validation all providing improve pre-term for strengthen picture of births, to in pre-eclampsia from of to clinicians Sera’s of in our that pregnancy pregnancies. tests establish give affects designed XX% and common important will and further Jay more valuable to the test X%